Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Future Planet Capital

Investor type Private Equity Firm
Founders Douglas Hansen-Luke


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 47
Average round size
The average size of a deal this fund participated in
Portfolio companies 30
Rounds per year 6.71
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical Device
  • Software
  • Manufacturing

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Future Planet Capital:
Typical Co-investors
Future Planet Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Future Planet Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alter Venture Partners Luxembourg, Luxembourg
BDC Capital - Cleantech Practice Alberta, Calgary, Canada
Capital Now -
Concert Capital Partners Community of Madrid, Madrid, Spain
Cubo Capital Distrito Federal, Mexico, Mexico City
Dongguanshi Rongke Touzi China, Dongguang, Guangdong
LabCorp Burlington, North Carolina, United States
Madison Paige Capital New York, New York, United States
Peppermint Holding Berlin, Berlin, Germany
Profin Capital -
Qu Ventures -
Richard Rainwater Fort Worth, Texas, United States
Swicorp Ar Riyad, Riyadh, Saudi Arabia
The Edgewater Group Jersey City, New Jersey, United States
Tyler Florence Group California, Mill Valley, United States
University of Melbourne Australia, Melbourne, Victoria
Venesio family -
Xidihui Zichan China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Environmental Consulting
$12M12 Jan 2023 Pasadena, California, United States

Queen of Raw

Information Technology
15 Nov 2022 New York, New York, United States

Roslin Technologies

$15M03 Nov 2022 City of Edinburgh, Scotland, United Kingdom


Artificial Intelligence
Machine Learning
Medical Device
26 Aug 2022 Birmingham, England, United Kingdom

Forge Care

Home Health Care
22 Jul 2022 -


Artificial Intelligence
Machine Learning
Medical Device
25 May 2022 Birmingham, England, United Kingdom

Lineat Composites

Advanced Materials
Renewable Energy
$938K03 May 2022 Bristol, England, United Kingdom

Amlo Biosciences

$3M21 Apr 2022 Newcastle upon Tyne, England, United Kingdom


Medical Device
01 Mar 2022 London, England, United Kingdom
Vaccitech Raises $168M in Series B Financing

– Vaccitech Ltd from Oxford develops a proprietary platform to treat and prevent infectious diseases and cancer.
– The company raised $168m in Series B funding.
– The round was led by M&G Investment Management and attracted new investor Tencent, Gilead Sciences, Monaco Constitutional Reserve Fund, and Future Planet Capital among others.
– The new investment will be used to develop the company’s pipeline of product candidates targeting infectious disease (including MERS coronavirus and Herpes Zoster) and cancer (including non-small cell lung cancer).

Future Planet Invests in Vaccitech’s Series B Financing

Future Planet Capital invests in a $168m Series B financing announced today by Vaccitech Ltd.
– Future Planet joins other leading investors including M&G Investment Management, Tencent, Gilead Sciences, Monaco Constitutional Reserve Fund and fellow existing investor, Oxford Sciences Innovation.
– As part of the Series B financing, $43m in convertible loan notes previously issued by Vaccitech will convert into Series B shares, resulting in total gross proceeds to Vaccitech of $168m before expenses.
Future Planet Capital is a London-based investment firm focused on venture capital and private equity investments in early stage life sciences companies.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Future Planet Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: